Literature DB >> 1742208

Contribution to the study of septal fibrosis of the liver.

Z A Andrade1.   

Abstract

Cellular and vascular proliferation in the perisinusoidal area of the acinar zone III of the liver preceded the formation of septal fibrosis in rats repeatedly treated with intraperitoneal injections of pig serum. Deposition of type I, III, IV and V collagens and increased amounts of fibronectin and laminin were also observed. Immunochemical staining for actin, elastin and desmin better disclosed the rich vascularization of the fibrous septa. Hypertrophy and hyperplasia of sinusoidal fat-storing cells point to the main role of such cells in the process of septum formation, but other connective tissue cells, such as mast-cells, were also present. These changes seemed to result from stimulation of the sinusoidal macrophage/fat-storing-cell system by foreign material present in the pig serum. The model may be useful for further studies on pathogenesis of septal fibrosis of the liver.

Entities:  

Mesh:

Year:  1991        PMID: 1742208      PMCID: PMC2002318     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  20 in total

1.  Anaphylaxis in the rat. Immunohistochemical and histochemical studies of the liver.

Authors:  R H FENNELL; A SANTAMARIA
Journal:  Am J Pathol       Date:  1962-11       Impact factor: 4.307

2.  Immunohistochemical detection of proliferating lipocytes in regenerating rat liver.

Authors:  Y Tanaka; K M Mak; C S Lieber
Journal:  J Pathol       Date:  1990-02       Impact factor: 7.996

Review 3.  Experimental models of hepatic fibrosis: a review.

Authors:  H Tsukamoto; M Matsuoka; S W French
Journal:  Semin Liver Dis       Date:  1990-02       Impact factor: 6.115

4.  Incomplete septal cirrhosis: histopathological aspects.

Authors:  R Sciot; D Staessen; B Van Damme; W Van Steenbergen; J Fevery; J De Groote; V J Desmet
Journal:  Histopathology       Date:  1988-12       Impact factor: 5.087

5.  Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycan.

Authors:  D M Arenson; S L Friedman; D M Bissell
Journal:  Gastroenterology       Date:  1988-08       Impact factor: 22.682

Review 6.  Hepatic fibrosis. Correlation of biochemical and morphologic investigations.

Authors:  H Popper; S Uenfriend
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

7.  Relationship between connective tissue cells and fibronectin in a sequential model of experimental hepatic fibrosis.

Authors:  G Cenacchi; G Ballardini; L Badiali De Giorgi; C A Busachi; M Del Rosso; F B Bianchi; G Biagini; R Laschi
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1983

8.  Sequential behaviour of extracellular matrix glycoproteins in an experimental model of hepatic fibrosis.

Authors:  G Ballardini; A Faccani; M Fallani; S Berti; V Vasi; C Castaldini; G Biagini; S Garbisa; F B Bianchi
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1985

9.  Slow cirrhosis--or no cirrhosis? a lesion causing benign intrahepatic portal hypertension.

Authors:  D A Levison; J G Kingham; A M Dawson; A G Stansfeld
Journal:  J Pathol       Date:  1982-07       Impact factor: 7.996

10.  Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum-induced fibrotic rat liver.

Authors:  K Fujiwara; I Ogata; Y Ohta; S Hayashi; S Mishiro; K Takatsuki; Y Sato; S Yamada; K Hirata; H Oka
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

View more
  2 in total

Review 1.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

2.  Hepatic extracellular matrix alterations in dogs naturally infected with Leishmania (Leishmania) chagasi.

Authors:  Ferdinan Almeida Melo; Eliane Perlatto Moura; Raul Rio Ribeiro; Cíntia Fontes Alves; Marcelo Vidigal Caliari; Washington Luiz Tafuri; Kátia da Silva Calabrese; Wagner Luiz Tafuri
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.